Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

CLOBAZAM vs CLONAZEPAM: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

CLOBAZAM vs CLONAZEPAM: Safety Overview

Metric CLOBAZAM CLONAZEPAM
Total FAERS Reports 10,596 39,463
Deaths Reported 725 8,488
Death Rate 6.8% 21.5%
Hospitalizations 3,312 12,506
Average Patient Age 29.3 yrs 46.0 yrs
% Female Patients 49.1% 58.3%
FDA Approval Date Apr 15, 2019 Approved Prior to Jan 1, 1982
Manufacturer NorthStar RxLLC Advagen Pharma Ltd
Route ORAL ORAL
Marketing Status Discontinued Prescription